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1. Introduction
The public’s demand for facial beauty has increased over time. Different cosmetic procedures
have been introduced to meet this demand. The essentials of facial cosmetic surgery are: 1-
Volume replacement and 2- Facial augmentation. Better aesthetic results have been achieved
by using less invasive surgical techniques including lifting procedures, injectable fillers,
autologous fat transfer, and facial implants.
The malar eminence and chin are the most common facial sites augmented via implants.
Autologous tissues have been the gold standard for facial augmentation for years; but today
alloplastic materials are more commonly used.
Drawbacks of autogenous grafting include: donor site morbidity, limited availability, limited
moldability, and unpredictable resorption [1].An ideal alloplastic implant must be made out
of a material that has low bioactivity or toxicity. It must also be stable and biocompatible [2].
An understanding of these qualities is needed to prevent complications or to treat them should
they occur.
2. The aging process
One of the primary advancements in cosmetic facial surgery has been the realization of volume
loss in aging and volume replacement via cosmetic surgery [3-6]. The abundance of midfacial
volume is one of the main reasons that makes a person look young, which means having the
right amount of fat in the right areas of the face. The loss or shift of this fat is a main contributor
to facial aging [7]. Loss of volume and volume shift occur in all regions of the face and neck
and are the reasons for aged appearance [5, 6].The youthful midface has voluminous and
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superiorly positioned malar fat pads. The malar fat pad is a triangular structure with its base
against the nasolabial fold and its apex over the malar region. Due to actinic skin changes as
well as gravity, fat atrophy, and deep connective tissue laxity, the malar fat pads lose volume
and descend lower into the face with age. The sum of these aging changes frequently yields a
hollow midface.
3. Treatment
There are a wide variety of procedures for achieving volume replacement and facial augmen‐
tation including lifting procedures [7, 8], injectable fillers [9-11], autologous fat transfer [12,
13], and facial implants [14, 15]. Facial implants are an optimum for most patients. The main
advantage is that they are a permanent option when compared with fillers; and they are
available in many anatomical shapes and sizes. They are easily placed, the recovery is minimal,
and they have a low complication rate.
Autogenous bone and cartilage have been used to repair traumatic, congenital, and surgical
defects of the face. The increased morbidity of the donor site, limited supply, resorption, and
migration contributed to decrease in their use. Gold, silver, paraffin, and ivory fell out of favor
because of their tissue incompatibility and lack of malleability. Polymeric silicone, polyamide
mesh, expanded polytetrafluoroethylene, and high-density polyethylene, replaced the
previous materials because of their increased malleability and biocompatibility [16].
The midface is the area in which facial implants are more commonly used. Implants in the
nasojugal crease are used to correct tear trough deformity. Nasal implants are not widely used,
but can be used to correct defects caused by rhinoplasty. Malar and submalar implants (Figure
1) are the most commonly used implants in the midface [17].
The lower face is another area where facial implants are frequently used. Chin implants
(Figure 2) are one of the most common facial implants performed by cosmetic surgeons [18].
Volume restoration, in addition to the re-suspension and removal of excess tissue, remains the
current goal of aesthetic surgery. Facial implants play a major role in volume restoration.
4. Implant types
Facial implants are categorized according to their site (malar, submalar, paranasal, chin, etc.).
They can also be prefabricated, anatomical or custom-made. Facial implants are available in
many shapes and sizes. The submalar implant is best described as an implant that restores the
volume the patient has lost with age. This is in contrast to malar augmentation, which generally
changes a patient’s appearance while augmenting volume. Volume is lost in the malar region
but is significantly less than the volume lost in the submalar region. Smaller implants generally
restore a former appearance, whereas larger implants change the patient’s appearance. The
submalar zone is the area of maximum midface atrophy in most patients. Most female patients
A Textbook of Advanced Oral and Maxillofacial Surgery Volume 2550
are treated with a small submalar implant. The medium implant is most frequently used in
the male patient. If the patient is looking for replacement of atrophic losses that occur with
aging, the smaller implant is preferable. A larger implant is reserved for the patient who desires
to not only replace volume that has been lost but also augment an appearance that was
previously unsatisfactory to the patient. Microgenia is effectively addressed with chin
augmentation [19, 20]. The placement of an extended alloplastic anatomic chin implant is a
simple, safe, and easily performed procedure. The patient’s appearance is enhanced by
restoring the chin and cervico-mental region [21, 22]. Most patients with a mild to moderately
deficient chin are well treated with an alloplastic implant [19]. In patients with severe micro‐
genia, a chin implant combined with soft tissue filling and tension restoration is most effective. 
 
 
                        Figure 1. Malar augmentation with facial implant. Above: Before. Below: After.





                       
 
Figure 2. Chin augmentation with facial implant, Above: Before, Below: After.
Facial implants are made of various materials. It is crucial that the surgeon be familiar with
these materials and their advantages and disadvantages.
4.1. Metal implants
Cobalt chromium alloys, stainless steel, gold, and titanium have been used as facial implants.
The corrosive characteristics of metals placed in the body limited their use. Stainless steel was
used in the plating of skeletal fractures of the face. Titanium has largely replaced stainless steel
and cobalt-chromium alloys as the metal of choice because of its strength, low tissue reactivity,
reduced artifact on CT, safety during MRI studies and its corrosive resistance over time [23].
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Its use is generally limited to dental implants and facial skeletal plating for maxillofacial
trauma [1, 24, and 25].
4.2. Silicone implants
Silicone implants have been used for years. Polydimethylsiloxane is nonporous implant with
smooth contours. Its pliable nature and resistance to high temperatures used in sterilization
make it the most versatile facial implant. It also can be easily carved and shaped. Polydime‐
thylsiloxane becomes encapsulated in a mild chronic inflammatory process. Because no links
are formed between the polydimethylsiloxane and its fibrous tissue envelope, they are more
prone to displacement, persistent seromas and a tendency toward extrusion [26-29].
4.3. Polyester fiber
Polyester fiber is comprised of nonabsorbable strands of polyethylene terephthalate which is
a porous material, allowing tissue ingrowth and subsequent implant stability. The excellent
tensile strength, durability, biocompatibility, and flexibility of polyester fiber have led to its
use in facial implants. Infection rates are lowered with antibiotic impregnation [30, 31]. Its
disadvantages are the surgical time required to prepare the mesh with folding and suturing
and inflammatory reactions most commonly seen after facial trauma [32].
4.4. Polyamide mesh
Polyamide mesh is an organopolymer related to nylon. It has the advantage of flexibility,
ease  of  molding  and allowing tissue  ingrowth into  the  implant  which  is  related  to  the
implant stability.  Polyamide mesh creates an intense foreign body response and chronic
inflammation. Hydrolytic degradation has been noted to occur after implantation, leading
to loss of volume [33].
4.5. High-density polyethylene
High-density polyethylene (HDPE) which is more commonly known as ‘‘Medpor’’ (Prex
Surgical, Inc., College Park, Georgia), is a stable, porous and extremely inert implant with
minimal foreign body reactions which does not degrade over time. It is malleable when heated
but otherwise has a lack of pliability. Although the large average pore size encourages fibrous
tissue ingrowth, leading to firm attachment and high stability [34, 35], but fibrous ingrowth
does not guarantee stability of HDPE implants against bone and may require additional
fixation.
4.6. Polymethylmethacrylate
Polymethylmethacrylate (PMMA) has high strength and rigidity for bony reconstruction of
the face. It has been used to repair orbital, malar, and cranial defects [36-38]. PMMA is available
as a powder consisting of polymer and catalyst and a liquid form of the monomer. When mixed,
an exothermic reaction occurs. The heat generated by the reaction has led to untoward events
in orthopedic surgery, although such complications have not been reported in craniofacial
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reconstruction. PMMA is well tolerated without significant inflammatory foreign body
reactions. Being able to create customized implants unique to each patient’s needs is one of its
main advantages.
4.7. Expanded polytetrafluoroethylene
ePTFE known as ‘‘Gore-Tex’’ (W.L.Gore and Associates, Flagstaff, AZ), is a fibrillated polymer
of polytetrafluoroethylene, with pores between the fibrils averaging 22 microns in diameter
which allows limited soft tissue ingrowth while creating only a mild chronic inflammatory
response, providing early stabilization and permitting removal when necessary [39]. ePTFE is
spongy in consistency, inert, and does not change shape or resorb with time. It also has been
found to be non-carcinogenic and is rarely allergenic [28, 40]. Because ePTFE is hydrophobic,
it does not absorb antibiotic solutions [41].
4.8. Hydroxyapatite
Calcium hydroxyapatite is mixed in a fashion similar to methylmethacrylate to form a cement
that can be contoured to each individual patient’s needs. Because it forms the synthetic,
inorganic constituent of bone, it can induce osseointegration. Mixing does not result in an
exothermic reaction. It is now used more commonly as an injectable implant.
5. Implant selection
The surgeon must be able to make a decision regarding the selection of an implant based on
chemical composition, physical structure, and planned site for application. Characteristics of
an ideal implant include biocompatibility, chemical inertness, lack of elicitation of foreign body
or hypersensitivity reaction, non-carcinogenicity, and ease of shaping and carving [42].
Common implant materials include expanded PTFE, methyl methacrylate, porous polyethy‐
lene, and silicone rubber. Porous polyethylene and silicone rubber implants are the most
commonly used. Silicone rubber implants can be easily trimmed, being flexible, conform well
to underlying anatomy and become well encapsulated. They can be easily be removed or
replaced if necessary.
The structure of porous polyethylene implants allows better tissue integration, but this can
also be extremely problematic when attempting to remove or replace an implant. Significant
tissue injury, defects or implant fragmentation can occur with removal.
Most patients, as they age, lose volume in the submalar region. The submalar area includes
the hollow area of the infraorbital, anterolateral maxillary region, and canine fossa regions.
Most of these patients have a hollow submalar region. They usually have adequate and well-
defined zygomatico-malar esthetics and adequately projected cheekbones. These patients are
best treated with only submalar augmentation, as their problem is loss of submalar volume.
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The second type of common facial esthetic deficiency found is in patients who have adequate
submalar and anterior maxillary projection but deficient cheekbones and hypoplasia of the
zygomatico-malar regions. These patients are best treated with a malar implant.
The third type of common midfacial aging change is seen in a patient who has submalar
deficiency in addition to need of more zygomatico-malar augmentation. These patients need
both submalar and malar augmentation. These patients are well treated with the combined
submalar shell implant. This implant is designed to augment the submalar region as well as a
portion of the zygomatico-malar region.
Careful examination and thorough analysis aid in coming to a decision about what size of
implant to use to achieve the desired effect [43]. Clinical photography serves as a powerful
tool. A similar approach is applied to the chin and prejowl complex. This approach helps
determine what type of implant to use.
Fewer surface imperfections allow greater resilience against degradation by mechanical forces
[44]. This advantage must be balanced with the increased possibility of migration as compared
with porous implants. The implant should not create a severe immune response, one that may
harm the host or damage the implant. Synthetic implants stimulate inflammatory response
with acute and chronic phases [45]. Significant immunogenicity can result in degradation or
rejection of the implant. Bacteria are capable of implant invasion when pore size decreases.
Implants with pore sizes between 1 and 50 microns may be more susceptible to infection than
materials with larger pores, because they do not permit tissue granulation and delivery of host
inflammatory cells to mount an adequate immune response.
6. Implant placement
6.1. Malar and submalar augmentation
The placement of midfacial implants is a simple surgical procedure for experienced maxillo‐
facial surgeons. The implants are always placed in the subperiosteal plane. With the exception
of the infraorbital neurovascular bundle, there is little vulnerable anatomy in the midface
region, when dissecting in the subperiosteal plane. The implants can also be placed concomi‐
tantly with other esthetic or orthognathic procedures.
With the patient in the sitting position, the atrophic submalar area is marked and the zygomatic
arch is outlined. The patient is prepared and draped. Several approaches to the malar and
submalar region exist including subciliary, transconjunctival, and intraoral. The intraoral
approach if preferred. The procedure is begun by injecting about 5 mL of 2% lidocaine with
1:100,000 epinephrine in the subperiosteal plane along the anterior maxilla, malar region, and
the anterior zygomatic arch region. An incision is made just below the maxillary vestibule,
approximately 1 cm above the canine tooth (Figure 3). The mucosa and soft tissues are incised
in the canine fossa region and through the periosteum. Subperiosteal dissection is performed
(Figure 4).
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Figure 3. Intraoral approach for malar implant placement
Figure 4. Subperiosteal dissection for malar implant placement
The borders of this dissection pocket are the lateral portion of the inferior orbital rim, superi‐
orly, the zygomatic arch superolaterally and the masseteric fascia laterally. The buccal fat pad
must be avoided. The extent of the dissection is dictated by the shape and size of the implant.
The combined submalar and shell implants require more dissection over the malar and
zygomatic regions. The dissected pocket should be just slightly larger than the actual implant
size. As the subperiosteal dissection is begun in the anterior maxillary region, it is important
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to protect the infraorbital neurovascular bundle. After the anterior maxilla is dissected, the
periosteal elevator is angled and the remainder of the dissection is primarily in an oblique
vector over the malar region and extends over the anterior portion of the zygomatic arch. After
the implant pocket is dissected, the area is checked for hemostasis (Figure 5). The pocket is
then irrigated with antibiotic solution (300 mg of clindamycin and or gentamicin mixed with
30 mL of sterile water) and the implant is placed. The implants are also soaked in antibiotic
solution. This is especially important for porous implants (Figure 6).
Figure 5. The subperiosteal pocket is checked for hemostasis
Figure 6. The implants are also soaked in Gentamicin solution
Facial Augmentation with Implants
http://dx.doi.org/10.5772/59188
557
A well-conforming implant in a tight pocket does not generally need fixation. If the pocket is
considerably larger than the implant and there is increased mobility of the implant, a single
fixation screw can be placed. The fixation screw is best placed in the thicker bone of the buttress
area (Figure 7). Finally, the incision is closed with interrupted 4-0 absorbable suture (Figure 8).
Figure 7. Implant fixation
Figure 8. Incision closureChin augmentation
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There are two main approaches to chin augmentation; one with an intraoral incision, and one
with an incision in the submental crease. The main advantage of the intraoral incision is the
avoidance of an external scar. The submental incision is preferred because the external scar is
well camouflaged in the submental crease and there is no need to divide the mentalis muscle.
A 2-cm incision is made in the submental crease centered about the midline. Sharp and blunt
dissection is used to reach the periosteum of the lower edge of the mandible in the midline. A
sharp incision is made through the periosteum laterally. A subperiosteal dissection is per‐
formed to create a pocket for the implant. Dissection laterally should be performed as close to
the mandibular border as possible to avoid injuring the mental nerve. After the implant is
inserted a stabilizing stitch or screws may be used. The incision is then closed in two layers.
When using an intra-oral approach, a 2 to 3-cm incision is made in the mandibular labial sulcus
about 10 to 15-mm away from mucogingival junction (Figure 9). Then the mentalis muscle and
periosteum are transected and a subperiosteal dissection is performed (Figure 10). Care must
be taken not to injure the mental nerve.
The implant is inserted over the chin bone and screws are used for fixation (Figures 11 and
12). Then the mentalis muscle portions are aligned and sutured together. The mucosa is closed
with absorbable sutures.
Figure 9. Intra-oral approach for chin implant placement
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Figure 10. Subperiosteal dissection for chin implant placement
Figure 11. Implant placement
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Figure 12. Implant fixation
7. Postoperative sequelae
The patient must be warned that during the first 1 to 2 weeks he or she will experience abnormal
animation when smiling and talking. The tissue dissection violates the orbicularis oris and lip
elevator muscles, which heal uneventfully with the return of normal animation. Significant
edema is not uncommon, especially with larger implants and in the early postoperative period.
Cold packs and steroids are routinely used. Severe swelling may indicate hematoma formation
and, if necessary it must be drained. This can usually be done by opening the incision and
suctioning the blood or clot from under or around the implant without compromising the
result. Minor hematomas will usually heal uneventfully without treatment. Occasionally,
subconjunctival or periorbital ecchymosis is seen but remains a rare occurrence and heals
uneventfully.
8. Post operative care
No dressings are required and the postoperative care includes analgesics, antibiotics, and
steroids if desired. The patient is instructed to avoid significant talking and animation for the
first 48 hours and is asked to follow a liquid or soft diet for the same period. Ice packs are used
for the first 24 hours.




9.1. Improper selection or placement
Improper placement of the implant is the most common complication followed by improper
implant selection. The implant should be slightly smaller than the desired increase in fullness.
Selecting too large an implant will lead to excessive soft tissue tension, which could lead to
ischemia, necrosis, or extrusion. Placement of malar implants too laterally can cause the eyes
to look too close together. Placement of the implants too medially and inferiorly will give a
chipmunk look or appearance.
9.2. Neuropraxia
Neuropraxia can occur from impingement of the nerve by a large implant, migration or
improper placement of the implant, a traction injury, a thermal injury, or a direct traumatic
injury from dissection. Most patients regain sensation and function within three weeks.
Dissection for Malar implants involves elevating tissue around the infraorbital nerve. Weak‐
ness of the zygomaticus, orbicularis oculi, or the frontalis muscles can be induced by disturb‐
ance of the temporofrontal branch of the facial nerve while dissecting posteriorly over the
middle third of the zygomatic arch. Straying from the subperiosteal plane predisposes to
dissection into the parotid and facial nerve branches and facial musculature. During dissection
of the chin, it is important to avoid the mental nerve, which is approximately underneath the
area of the premolars intraorally. The marginal mandibular branch of the facial nerve, which
supplies muscles of the lower lip and chin, is above the periosteum over the inferior border of
the mandible. A severe traction injury or perforation of the periosteum can injure the marginal
mandibular branch of the facial nerve.
9.3. Edema and ecchymosis
The majority of postoperative edema and ecchymosis resolves in two weeks, but edema can
persist for 6 months and even up to a year [46]. Implant fixation is important because excessive
continuing movement can cause tissue injury, chronic inflammation, and suboptimal soft
tissue acceptance with prolonged edema. This could also be due to a nonspecific immune
reaction to the implant material.
9.4. Hematoma and seroma
Abnormal fluid collection can be the result of inadequate hemostasis, over-dissection, trau‐
matic handling of the tissues, dead space around or underneath the implant or elevated blood
pressure. Hematomas and seromas encourage the growth of bacterial contamination potenti‐
ating cellulitis and infection. They can result in excessive fibrosis producing soft tissue defects.
Smaller hematomas (<5 cc) resolve without treatment in 10–14 days. Large hematomas need
to be recognized and evacuated with the implant removed as necessary. Seromas usually
present around 2 weeks after surgery. Presence of liquefied hematomas or seromas 2 to 4 weeks
postoperatively may be drained percutaneously [47].
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9.5. Infection
Implants can be contaminated by hematogenous, contiguous spread, or direct inoculation.
Foreign bodies have been shown to reduce the number of bacteria required to produce an
infection by 104 to 106 power [48]. Chemical composition, surface roughness, surface config‐
uration, and hydrophobicity influence the potential for implant contamination. Hydrophilic
materials are more resistant to adhesion than hydrophobic materials. Scalfani and colleagues
found that PTFE with an average pore size of 22 microns became infected at lower inoculum
counts and sooner than polyethylene with a pore size of 150 microns [48]. Most infections in
the early postoperative time period are more likely to occur with porous implants because of
increased surface area, irregularity, and surface energy, which facilitates bacterial adherence.
Infections that occur years after surgery are most probably caused by hematogenous spread
or direct violation of the implant capsule with bacterial seeding like an injection. Late malar
implant infections have been associated with dental injections as reported by Cohen and
Kawamoto [49].
S. aureus is the main pathogen and is usually susceptible to penicillin or cephalosporin. A
better chance of eradicating the infection with antibiotics and drainage is possible with
nonporous implants. In the presence of a purulent infection, the implant should be removed
and scrubbed and sterilized to remove the biofilm. In addition, debridement and copious
irrigation of the implant pocket and a prolonged postoperative antibiotic course are necessary.
If rapid improvement does not occur and the implant needs to be removed, it should not be
replaced for 6–8 weeks to allow for resolution of the infection and inflammation [50].
9.6. Migration and contour changes
Migration is usually the result of over dissection, improper implant size selection and lack of
fixation. Supraperiosteal placement can predispose the implant to mobility especially without
adequate fixation. Anatomic implants have decreased the potential for migration, rotation,
and displacement. Delayed contour changes have been reported in association with silastic
implants. This is thought to be associated with capsular contracture around the implant in
addition to calcification of the capsule itself.
9.7. Extrusion
Adequate soft tissue bulk with good quality tissue for coverage of the implant and tension-
free correct plane insertion are critical to preventing implant extrusion. Decreased tissue
perfusion causes wound healing problems. Highly scarred and thinned tissues tend to atrophy
over time and are at a higher risk for postoperative infection, exposure, and extrusion [35].
Excessive tension is a result of placing too large an implant in a small pocket. In addition to
tension free closure, subperiosteal placement helps prevent exposure.
9.8. Palpability
This can be the result of improper implant size selection, improper contour selection, improper
positioning, improper fixation or capsular contracture. Thin overlying tissue and supraper‐
iosteal placement of the implant predispose to palpability.




Altered lip function occurs because dissection can interfere with the muscles responsible for
smiling mimetics. Other factors include edema, interposition of a solid implant which stretches
the muscles of the midface, or interference with the facial nerve during dissection over the
zygomatic arch. The edema can cause dysfunction in the muscles of the lips resembling facial
nerve dysfunction. When dysfunction is due to muscle displacement, it usually takes 1–3
months for the muscles to reattach and the capsule to become soft and distensible.
9.10. Bone resorption
Bone erosion under alloplastic implants was a significant problem with early implants. It was
often attributed to foreign body reaction between the implant and the bone or to pressure from
the mentalis muscle against the implant. Improper implant positioning, pressure due to an
oversized implant, subperiosteal placement and hardness of the implant were also considered.
The resorption from anatomic malar and chin implants is minimal and self-limiting. Bone
erosion occurs less with anatomic extended implants because of greater distribution of the
pressure forces over a broader anatomic area. Resorption appears to occur in the first 12 months
after placement but can appear radiographically as soon as 2 months. Labial incompetence and
hyperactive mentalis lead to pressure and migration of the implant superiorly onto the thinner
bone of the alveolus, which predisposes to resorption. When severe resorption is present, the
implant must be removed.
9.11. Postoperative asymmetry
Asymmetry is more likely to be noticed in malar implants. It is usually caused by initial
malposition or by creation of asymmetric bilaterally dissected spaces. It can also be the result
of unrecognized preoperative skeletal or soft tissue deficiencies. It is important to point out
preexisting asymmetry before treatment selection. Although major asymmetries require a
second surgery, minor asymmetries have a natural tendency to adjust and correct themselves
over a 6-month postoperative period as healing progresses and the tissue around the implant
relaxes and softens.
10. Summary
Loss of volume and volume shift occur in all regions of the face and neck and contribute to the
aged appearance. Volume replacement and contour augmentation of the face are the essentials
of facial cosmetic surgery. The development of less invasive volume replacement procedures
has been an evolution in achieving better aesthetic results. These procedures include lifting
procedures, injectable fillers, autologous fat transfer, and facial implants.
Facial volume augmentation by using facial implants is a very safe procedure that is used
widely for facial rejuvenation which can be used concomitantly with other rejuvenation
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procedures. It is crucial for the cosmetic surgeons to be familiar with various implant materialsand their advantages and disadvantages.
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